Journal of
Public Health and Epidemiology

  • Abbreviation: J. Public Health Epidemiol.
  • Language: English
  • ISSN: 2141-2316
  • DOI: 10.5897/JPHE
  • Start Year: 2009
  • Published Articles: 474

Full Length Research Paper

Prevalence of hepatitis B and C among HIV/AIDS patients attending Bingham University Teaching Hospital Jos Plateau State Nigeria: A retrospective study

Odjimogho Stella
  • Odjimogho Stella
  • Department of Public and Community Health Novena University Ogume, Nigeria.
  • Google Scholar
Agofure Otovwe
  • Agofure Otovwe
  • Department of Public and Community Health Novena University Ogume, Nigeria.
  • Google Scholar
Oghenenioborue R. A Okandeji-Barry
  • Oghenenioborue R. A Okandeji-Barry
  • Department of Public and Community Health Novena University Ogume, Nigeria.
  • Google Scholar
Ibrahim Zainab Ladidi
  • Ibrahim Zainab Ladidi
  • Department of Public and Community Health Novena University Ogume, Nigeria.
  • Google Scholar


  •  Received: 27 December 2017
  •  Accepted: 26 February 2018
  •  Published: 30 June 2018

References

Adekeye AM, Chukwuedo AA, Zhakom PN, Yakubu RS (2013). Prevalence of Hepatitis B and C among Blood Donors in Jos South LGA, Plateau State, Nigeria. Asian Journal of Medical Sciences, 5(5):101-104.

 

Agbede OO, Iseniyi JO, Kolawole MO, Ojuawo A (2007). Risk factors and seroprevalence of hepatitis B surface antigenaemia in mothers and their pre-school age children in Ilorin. Niger. Ther. 4(1):67-72.

 

Agwale SM, Tanimoto L, Womack C, Odama L, Leung K, Duey D (2004). Prevalence of HCVcoinfection in HIV-infected individuals in Nigeria and characterization of HCV genotype. Journal of Clinical Virology Supplement, 1:S3-6.
Crossref

 

Baba MM, Gushau W, Hassan AW (1998). Detection of hepatitis-B surface antigenaemia in patients with and without the manifestations of AIDS in Maiduguri, Nigeria. Postgraduate Medical Journal, 5(3):125-127.

 

Balogun TM, Emmanuel S, Ojerinde EF (2012). HIV, Hepatitis B and C viruses' co-infection among patients in a Nigerian tertiary hospital. Pan African Medical Journal, 12:100.

 

Centre for Disease Control (1993). 1992 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41(RR–17):961-962.

 

Diop‐Ndiaye H, Touré‐Kane C, Etard JF, Lo G, Diaw PA, Ngom‐Gueye NF, Gueye PM, Ba‐Fall K, Ndiaye I, Sow PS, Delaporte E (2008). Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation. Journal of Medical Virology, 80(8):1332-1336.
Crossref

 

Diwe CK, Okwara EC, Enwere OO, Azike JE, Nwaimo NC (2013). Sero-prevalence of hepatitis B virus and hepatitis C virus among HIV patients in a suburban University Teaching Hospital in South-East Nigeria. Pan African Medical Journal, 16:7.
Crossref

 

Ejele OA, Ojule AC (2004). The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Nigerian Journal of Medicine, 13(4):336-8.

 

Forbi JC, Gabadi S, Alabi R, Iperepolu HO, Pam CR, Entonu PE, Agwale SM (2007). The role of triple infection with hepatitis Bvirus, hepatitis C virus, and human immunodeficiency virus(HIV) type -1 on CD4+ lymphocyte levels in the highly HIV infected population of North Central Nigeria. Mem. Inst. Oswaldo Cruz. 102(4):535-537.
Crossref

 

Greub G (2000). Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C co infection, Swiss HIV cohort study. Lancet 356:1800-1805.
Crossref

 

Iser DM, Avihingsanon A, Wisedopas N, Thompson AJ, Boyd A, Matthews GV, Locarnini SA, Slavin J, Desmond PV, Lewin SR (2011). Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression. AIDS 25(2):197-205.
Crossref

 

Lacombe K, Boyd A, Gozlan J, Lavocat F, Girard PM, Zoulim F (2010). Drug resistance and immune escape HBV mutants in HIV-infected hosts. Antiviral Therapy, 15:493-497.
Crossref

 

Larsen C, Pialoux G, Salmon D, Antona D, Le Strat Y, Piroth L, Pol S, Rosenthal E, Neau D, Semaille C, Astagneau ED (2008). Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France. Euro. Surveill. 13(22):18888.

 

Lesi OA, Kehinde MO, Oguh DN, Amira CO (2007). Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Niger. Postgraduate Medical Journal,14(2):129-33.

 

Macias J, Japón MA, Sáez C, Palacios RB (2005). Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection. Infectious Diseases, 192(9):1566-1576.
Crossref

 

Madhava V, Burgess C, Drucker E (2002). Epidemiology of chronic hepatitis C virus infection in subSaharan Africa. Lancet Infectious Diseases, 2(5):293-302.
Crossref

 

Matthews PC, Gerettic AM, Gouldera PJR, Klenermana P (2014). Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa. Journal of Clinical Virology, 61:20-33.
Crossref

 

Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S (2005). Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas. Japanese Journal of Infectious Diseases, 58(1):15-9.

 

Modi AA, Feld JJ (2007). Viral hepatitis and HIV in Africa. AIDS Rev. 9(1):25-39.

 

Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA (2013). Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Research Notes 6:363.
Crossref

 

Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL (2015). Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis. Nigerian Journal of Clinical Practice, 18(2):163-172.
Crossref

 

Olatunji OP, Iseniyi JO (2008). Hepatitis B and C viruses' co-infection with human immunodeficiency virus infected patients at UITH, IIorin. Nigerian Medical Practitioner, 54(1):8-10.
Crossref

 

Opaleye OO, Oluremi AS, Ogbolu DO, Babalola BA, Shittu T, Adesiyan AA (2014). Prevalence of hepatitis- B virus infection among HIV patients in Ikole Ekiti, South–Western, Nigeria. Asian Pacific Journal of Health Sciences, 1(4):507-511.

 

Parboosing R, Paruk I, Lalloo UG (2008). Hepatitis C virus seropositivity in a South African cohort of HIVinfected, ARV naive patients is associated with renal insufficiency and increased mortality. Journal of Medical Virology, 80(9):1530-1536.
Crossref

 

Sonderup MW, Spearman W (2015). HIV/HBV and HIV/HCV Co-infection in Sub-Saharan Africa: Transmission, Disease Outcomes, and Treatment Options. 

View

 

Sungkanuparph S, Vibhagool A, Manosuthi W, Kiertiburanakul S, Atamasirikul K, Aumkhyan A, Thakkinstian A (2004). Prevalence of hepatitis B virus and hepatitis C co infection with human immunodeficiency virus in Thai patients: a tertiary case based study. Journal of the Medical Association of Thailand, 87(11):1349-1354.

 

Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ (2012). Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. African Health Sciences, 12(3):312-317

 

Joint United Nations Programme on HIV and AIDS (UNAIDS) (2017). An overview of HIV/AIDS in Nigeria.

 

World Health Organization (WHO) (2000). Women and HIV/AIDS: Key Facts and Issues Fact Sheet No. 242.

 

World Health Organisation (WHO) (2008). Hepatitis B [database on the Internet] World Health Organization. 

View

 

World Health Organisation (WHO) (2011). Hepatitis C [database on the Internet] World Health Organization.

View

 

World Health Organisation (WHO) (2017). Global Health Observatory (GHO) data on HIV/AIDS. Geneva Switzerland.